3
Announcements
Trials
Browse
Landscape
Phase
Phase 4
1
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Gastrointestinal
1
Conditions
Pain, Postoperative
1
Colonic Neoplasms
1
Agnosia
1
Abdominal Pain
1
Interventions
Dexamethasone
12
Bevacizumab
9
Saline Solution
8
Bupivacaine
8
Tobacco Use Cessation Devices
7
Specimen Handling
7
Nivolumab
7
Magnetic Resonance Spectroscopy
7
Rituximab
6
Prednisone
6
Letrozole
6
Lenalidomide
6
Fluorouracil
6
Cisplatin
6
Carboplatin
6
pembrolizumab
5
Sodium Chloride
5
Ropivacaine
5
Human Papillomavirus Recombinant Vaccine nonavalent
5
Trastuzumab
4
Tamoxifen
4
Standard of Care
4
Propofol
4
Paclitaxel
4
Immune Checkpoint Inhibitors
4
Esomeprazole
4
Enoxaparin
4
Doxorubicin
4
Bortezomib
4
Bismuth
4
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Phase 4
×
Bulk Drugs
×
1 year
×
Clear all
NCT04311099
2025-08-07
OPMICS
Nordsjaellands Hospital
Phase 4
Completed
360 enrolled